Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
STS101 for the acute treatment of migraine	STS-101 (TO-2070, dihydroergotamine)	Migraine	Neurology	2022	View \| Download
Subcutaneous atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed and/or refractory multiple myeloma	Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst) , Subcutaneous isatuximab	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2023	View \| Download
Subcutaneous Tocilizumab (RoACTEMRA) With or Without Methotrexate for the Treatment of Inadequate Responders in Systemic Juvenile Idiopathic Arthritis	Methotrexate (MTX; Otrexup; Vibex MTX; MQX-5902; methotrexate disodium; methotrexate sodium) , Tocilizumab (Actemra; R1569; RoActemra)	Juvenile idiopathic arthritis	Rheumatology	2017	View \| Download
Sutimlimab for primary cold agglutinin disease	Sutimlimab (BIVV009; TNT009)	Cold agglutinin disease (CAD)	Haematology , Immunology	2018	View \| Download
Synthetic hypericin (SGX301; VIMRxyn) for cutaneous T‐cell lymphoma, unspecified	Hypericin (SGX301; HBP-347)	Cutaneous T-cell lymphoma (CTCL)	Haematological Cancer and Lymphomas	2017	View \| Download
Tabelecleucel for Epstein-Barr Virus-associated lymphoproliferative disease following solid organ transplant	Tabelecleucel (Tab-cel; ATA129)	Post-transplant lymphoproliferative disease (PTLD)	Haematological Cancer and Lymphomas	2019	View \| Download
Tafamidis for Transthyretin Amyloid Cardiomyopathy	Tafamidis meglumine (Vyndaqel; Fx-1006A; PF-06291826)	Transthyretin amyloid cardiomyopathy	Cardiovascular System	2018	View \| Download
Tafasitamab in combination with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma	Tafasitamab (MOR208; Monjuvi)	Diffuse large B-cell lymphoma (DLBCL)	Haematological Cancer and Lymphomas	2020	View \| Download
Tafasitamab with lenalidomide as add-on therapy for previously treated follicular lymphoma or marginal zone lymphoma	Lenalidomide (Revlimid) , Tafasitamab (MOR208; Monjuvi)	Follicular lymphoma , Marginal zone lymphoma (MZL)	Haematological Cancer and Lymphomas	2023	View \| Download